Firmenich opens biotech and naturals pilot plant in Geneva for clean label ingredients
Firmenich has opened a new biotechnology and naturals pilot plant and laboratory in Geneva benefiting from the latest digital technology.
The company said the facility opens a new era for the development of ingredients and clean label solutions by providing faster speed-to-market and greater flexibility for customer collaboration.
The site is integrated into the Group’s flagship ingredients production site at La Plaine, Geneva, and the facility operates to the highest safety and environmental standards, reducing waste and energy consumption.
“With our new biotechnology pilot plant closely connected with the ingredients production site, Firmenich provides integrated biotech development all the way down to the finished product, without any gaps,” said Genevieve Berger, chief research officer, Firmenich. “Opening a new era in ingredients creation, our pilot plant and laboratory harnesses new technologies to improve clean label solutions, while the latest digital innovation maximises efficiency.”
“Our new pilot plant provides greater flexibility to respond to customer needs in product development,” said
Sarah Reisinger, senior vice president research operations, Firmenich. “Capable of handling multiple projects simultaneously, it also enables small scale production of trial batches for formulation or testing and regulatory validation.”
Operational this month, the pilot plant at La Plaine uses digital technology for increased automation. The pilot plant is able to move from single to continuous batch process, increasing efficiency, speed and reducing the use of
raw materials.